Insulin-like growth factor-I signaling in human neuroblastoma cells

Oncogene

Volumn 23, Issue 1, 2004, Pages 130-141

  Kim, Bhumsoo ^a   Van Golen, Cynthia M ^a   Feldman, Eva L ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

FAK; Insulin receptor substrate; Insulin like growth factor I; Neuroblastoma; Paxillin; Shc

Indexed keywords

FOCAL ADHESION KINASE; MITOGEN ACTIVATED PROTEIN KINASE; PAXILLIN; PROTEIN KINASE B; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C;

ARTICLE; CARCINOGENESIS; CELL ACTIVATION; CELL ADHESION; CELL MOTILITY; CELL STIMULATION; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; PHOSPHORYLATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; CELL LINE, TUMOR; CYTOSKELETAL PROTEINS; FOCAL ADHESION KINASE 1; FOCAL ADHESION PROTEIN-TYROSINE KINASES; HUMANS; INSULIN-LIKE GROWTH FACTOR I; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MITOGEN-ACTIVATED PROTEIN KINASES; NEURITES; NEUROBLASTOMA; PAXILLIN; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; RECEPTOR, IGF TYPE 1; SIGNAL TRANSDUCTION;

EID: 0942290417     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206924     Document Type: Article

References (77)

1. Anderson DJ. (1993). Annu. Rev. Neurosci., 16, 129-158.
2. Baltensperger K, Kozma LM, Cherniack AD, Klarlund JK, Chawla A, Banerjee U and Czech MP. (1993). Science, 260, 1950-1952.
3. Baserga R. (1995). Cancer Res., 55, 249-252.
4. Bellis SL, Miller JT and Turner CE. (1995). J. Biol. Chem., 270, 17437-17441.
5. Biedler JL, Helson L and Spengler BA. (1973). Cancer Res., 33, 2643-2652.
6. Biedler JL, Spengler BA, Tien-ding C and Ross RA. (1988). Adv. Neuroblastoma Res., 2, 265-276.
7. Brodeur GM. (2003). Nat. Rev. Cancer, 3, 203-216.
8. Chan JM, Stampfer MJ, Giovannucci E, Gann PH, Ma J, Wilkinson P, Hennekens CH and Pollak M. (1998). Science, 279, 563-566.
9. Cheatham B and Kahn CR. (1995). Endocr. Rev., 16, 117-142.
10. Cheng H-L, Steinway M, Delaney CL, Franke TF and Feldman EL. (2000). Mol. Cell. Endocrinol., 170, 211-215.
11. Ciccarone V, Spengler BA, Meyers MB, Biedler JL and Ross RA. (1989). Cancer Res., 49, 219-225.
12. Corvi R, Savelyeva L and Schwab M. (1997). J. Neurooncol., 31, 25-31.
13. DeClerck YA, Bomann ET, Spengler BA and Biedler JL. (1987). Cancer Res., 47, 6505-6510.
14. De Meyts P, Wallach B, Christoffersen CT, Urso B, Gronskov K, Latus L-J, Yakushiji F, Ilondo MM and Shymko RM. (1994). Horm. Res., 42, 152-169.
15. Devary Y, Gottlieb RA, Smeal T and Karin M. (1992). Cell, 71, 1081-1091.
16. Encinas M, Iglesias M, Llecha N and Comella JX. (1999). J. Neurochem., 73, 1409-1421.
17. Favrot MC, Combaret V, Goillot E, Lutz P, Frappaz D, Thiesse P, Thyss A, Dolbeau D, Bouffet E and Tabone E. (1991). Int. J. Cancer, 49, 347-355.
18. Feldman EL, Sullivan KA, Kim B and Russell JW. (1997). Neurobiol. Dis., 4, 201-214.
19. Flickinger KS, Judware R, Lechner R, Carter WG and Culp LA. (1994). Exp. Cell Res., 213, 156-163.
20. Franke TF, Kaplan DR and Cantley LC. (1997). Cell, 88, 435-437.
21. Frappaz D, Michon J, Coze C, Berger C, Plouvier E, Lasset C, Bernard JL, Stephan JL, Bouffet E, Buclon M, Combaret V, Fourquet A, Philip T and Zucker JM. (2000). J. Clin. Oncol., 18, 468-476.
22. Giancotti FG and Ruoslahti E. (1999). Science, 285, 1028-1032.
23. Giorgetti S, Pelicci PG, Pelicci G and Van Obberghen E. (1994). Eur. J. Biochem., 223, 195-202.
24. Greene MW, Sakaue H, Wang L, Alessi DR and Roth RA. (2003). J. Biol. Chem., 278, 8199-8211.
25. Guo HB, Lee I, Kamar M, Akiyama SK and Pierce M. (2002). Cancer Res., 62, 6837-6845.
26. Hankinson SE, Willett WC, Colditz GA, Hunter DJ, Michaud DS, Deroo B, Rosner B, Speizer FE and Pollak M. (1998). Lancet, 351, 1393-1396.
27. Haruta T, Uno T, Kawahara J, Takano A, Egawa K, Sharma PM, Olefsky JM and Kobayashi M. (2000). Mol. Endocrinol., 14, 783-794.
28. Hood JD and Cheresh DA. (2002). Nat. Rev. Cancer, 2, 91-100.
29. Ivankovic-Dikic I, Gronroos E, Blaukat A, Barth BU and Dikic I. (2000). Nat. Cell Biol., 2, 574-581.
30. Judware R and Culp LA. (1995). Oncogene, 11, 2599-2607.
31. Kim B, Cheng H-L, Margolis B and Feldman EL. (1998a). J. Biol. Chem., 273, 34543-34550.
32. Kim B and Feldman EL. (1998). J. Neurochem., 71, 1333-1336.
33. Kim B and Feldman EL. (2002). J. Biol. Chem., 277, 27393-27400.
34. Kim B, Leventhal PS, Saltiel AR and Feldman EL. (1997). J. Biol. Chem., 272, 21268-21273.
35. Kim B, Leventhal PS, White MF and Feldman EL. (1998b). Endocrinology, 139, 4881-4889.
36. Kurihara S, Hakuno F and Takahashi S. (2000). Endocr. J., 47, 739-751.
37. Lebrun P, Mothe-Satney I, Delahaye L, Van Obberghen E and Baron V. (1998). J. Biol. Chem., 273, 32244-32253.
38. Leventhal PS and Feldman EL. (1997). Trends Endocrinol. Metab., 8, 1-6.
39. Leventhal PS, Shelden EA, Kim B and Feldman EL. (1997). J. Biol. Chem., 272, 5214-5218.
40. Liu X, Turbyville T, Fritz A and Whitesell L. (1998). Cancer Res., 58, 5432-5438.
41. Meyer G and Feldman EL. (2002). J. Neurochem., 83, 490-503.
42. Meyer GE, Shelden E, Kim B and Feldman EL. (2001). Oncogene, 20, 7542-7550.
43. Miller TM, Tansey MG, Johnson Jr EM and Creedon DJ. (1997). J. Biol. Chem., 272, 9847-9853.
44. Myers Jr MG and White MF. (1996). Annu. Rev. Pharmacol. Toxicol., 36, 615-658.
45. Ogihara T, Shin BC, Anai M, Katagiri H, Inukai K, Funaki M, Fukushima Y, Ishihara H, Takata K, Kikuchi M, Yazaki Y, Oka Y and Asano T. (1997). J. Biol. Chem., 272, 12868-12873.
46. Parsons JT. (2003). J. Cell Sci., 116, 1409-1416.
47. Pederson TM, Kramer DL and Rondinone CM. (2001). Diabetes, 50, 24-31.
48. Pronk GJ, McGlade J, Pelicci G, Pawson T and Bos JL. (1993). J. Biol. Chem., 268, 5748-5753.
49. Reiss K, D'Ambrosio C, Tu X, Tu C and Baserga R. (1998). Clin. Cancer Res., 4, 2647-2655.
50. Reiss K, Wang JY, Romano G, Furnari FB, Cavenee WK, Morrione A, Tu X and Baserga R. (2000). Oncogene, 19, 2687-2694.
51. Rettig WJ, Spengler BA, Chesa PG, Old LJ and Biedler JL. (1987). Cancer Res., 47, 1383-1389.
52. Ross RA and Biedler JL. (1985). Cancer Res., 45, 1628-1632.
53. Ross RA, Spengler BA, Domenech C, Porubcin M, Rettig WJ and Biedler JL. (1995). Cell Growth Differ., 6, 449-456.
54. Rui L, Aguirre V, Kim JK, Shulman GI, Lee A, Corbould A, Dunaif A and White MF. (2001a). J. Clin. Invest., 107, 181-189.
55. Rui L, Fisher TL, Thomas J and White MF. (2001b). J. Biol. Chem., 276, 40362-40367.
56. Russell JW, Windebank AJ, Schenone A and Feldman EL. (1998). J. Neurobiol., 36, 455-467.
57. Salgia R, Li JL, Ewaniuk DS, Wang YB, Sattler M, Chen WC, Richards W, Pisick E, Shapiro GI, Rollins BJ, Chen LB, Griffin JD and Sugarbaker DJ. (1999). Oncogene, 18, 67-77.
58. Sarbassov DD and Peterson CA. (1998). Mol. Endocrinol., 12, 1870-1878.
59. Sasaoka T, Langlois WJ, Leitner JW, Draznin B and Olefsky JM. (1994). J. Biol. Chem., 269, 32621-32625.
60. Schaller MD. (2001). Oncogene, 20, 6459-6472.
61. Schmidt ML, Lukens JN, Seeger RC, Brodeur GM, Shimada H, Gerbing RB, Stram DO, Perez C, Haase GM and Matthay KK. (2000). J. Clin. Oncol., 18, 1260-1268.
62. Scibelli A, D'Angelo D, Pelagalli A, Tafuri S, Avallone L, Morte RD and Staiano N. (2003). Vet. Res., 34, 193-202.
63. Seiler AE, Ross BN and Rubin R. (2001). J. Neurochem., 76, 573-581.
64. Sieg DJ, Hauck CR, Ilic D, Klingbeil CK, Schaefer E, Damsky CH and Schlaepfer DD. (2000). Nat. Cell Biol., 2, 249-256.
65. Singleton JR, Randolph AE and Feldman EL. (1996). Cancer Res., 56, 4522-4529.
66. Thomas JW, Cooley MA, Broome JM, Salgia R, Griffin JD, Lombardo CR and Schaller MD. (1999). J. Biol. Chem., 274, 36684-36692.
67. Tumilowicz JJ, Nichols WW, Cholon JJ and Greene AE. (1970). Cancer Res., 30, 2110-2118.
68. Valentinis B, Navarro M, Zanocco-Marani T, Edmonds P, McCormick J, Morrione A, Sacchi A, Romano G, Reiss K and Baserga R. (2000). J. Biol. Chem., 275, 25451-25459.
69. Valentinis B, Romano G, Peruzzi F, Morrione A, Prisco M, Soddu S, Cristofanelli B, Sacchi A and Baserga R. (1999). J. Biol. Chem., 274, 12423-12430.
70. van Golen CM and Feldman EL. (2000). J. Cell. Physiol., 182, 24-32.
71. van Golen CM, Schwab TS, Woods Ignatoski KM, Ethier SP and Feldman EL. (2001). Cell Growth Differ., 12, 371-378.
72. Vincent AM and Feldman EL. (2002). Growth Horm. IGF Res., 12, 193.
73. Waters SB and Pessin JE. (1996). Trends Cell Biol., 6, 1-4.
74. Yee D. (2002). Semin. Oncol., 29, 86-95.
75. Yoshihara T, Esumi N, Humphries MJ and Imashuku S. (1992). Int. J. Cancer, 51, 620-626.
76. Yu H, Spitz MR, Mistry J, Gu J, Hong WK and Wu X. (1999). J. Natl. Cancer Inst., 91, 151-156.
77. Zumkeller W and Schwab M. (1999). Horm. Metab. Res., 31, 138-141.